Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$652K Buy
2,445
+25
+1% +$6.92K 0.01% 278
2025
Q4
$666K Hold
2,420
0.01% 268
2025
Q3
$698K Sell
2,420
-129
-5% -$38.2K 0.01% 264
2025
Q2
$843K Hold
2,549
0.02% 241
2025
Q1
$839K Sell
2,549
-17
-0.7% -$5.12K 0.02% 240
2024
Q4
$709K Buy
2,566
+23
+0.9% +$7.33K 0.01% 263
2024
Q3
$881K Hold
2,543
0.02% 250
2024
Q2
$841K Hold
2,543
0.02% 233
2024
Q1
$924K Buy
+2,543
New +$837K 0.02% 234

Other funds holding CI

Cannell & Spears's CI Position: Q1 2026 in Review

Cannell & Spears increased its Cigna (CI) stake by 1% in Q1 2026, buying an estimated $6.92K and bringing the position to 2,445 shares worth $652K. The position accounts for 0.01% of the portfolio, ranked #278.

Cannell & Spears first reported a position in CI in Q1 2024 and has held it in 9 quarters since. The position peaked at $924K in Q1 2024. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Cannell & Spears held 2,445 shares of Cigna worth $652K as of Q1 2026.
  • Cannell & Spears bought 25 Cigna shares in Q1 2026, an estimated $6.92K.
  • Cigna made up 0.01% of Cannell & Spears's portfolio in Q1 2026, its #278 holding.
  • Cannell & Spears first reported a position in Cigna in Q1 2024 and has held it in 9 quarters since.
  • Cannell & Spears's Cigna position peaked at $924K in Q1 2024.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.